Summary
Bunge Global SA (BG) has filed an 8-K report on June 13, 2025, announcing significant progress towards the closing of its previously announced acquisition. The company, along with the Designated Sellers (Glencore, CPPIB, and BCI), have entered into an amendment to the Business Combination Agreement. This amendment sets a new Closing Date for the Transactions, including the Acquisition, as July 2, 2025, and extends the Extended Outside Date to July 3, 2025. Crucially, certain conditions to closing have been waived or deemed satisfied, and Bunge has waived its right to terminate the agreement under specific circumstances, signaling a strong commitment to finalizing the deal. Furthermore, Bunge announced that it has received the necessary antitrust and foreign direct investment approvals from the State Administration for Market Regulation of the People’s Republic of China and the Federal Economic Competition Commission of the United Mexican States. With these key regulatory hurdles cleared, and subject to the satisfaction of any remaining conditions as modified by the amendment, Bunge and the Sellers anticipate consummating the acquisition on July 2, 2025. This filing provides greater certainty for investors regarding the near-term completion of this transformative transaction.
Key Highlights
- 1Bunge Global SA has amended its Business Combination Agreement with Designated Sellers (Glencore, CPPIB, BCI).
- 2The Closing Date for the acquisition is now officially set for July 2, 2025.
- 3The Extended Outside Date has been moved to July 3, 2025.
- 4Certain conditions precedent to closing have been waived or deemed satisfied by both parties.
- 5Bunge has waived its right to terminate the agreement in specific scenarios.
- 6Key regulatory approvals for antitrust and foreign direct investment have been secured from China and Mexico.
- 7The company expects to close the transaction on July 2, 2025, contingent on remaining conditions.